RSN Fundraising Banner
FB Share
Email This Page
add comment
Print

Becker writes: "Democratic presidential candidate Hillary Clinton on Monday urged U.S. regulators to determine how to bring lower-cost generic drugs to market more swiftly and combat anticompetitive practices in the pharmaceutical industry."

Presidential candidate Hillary Clinton speaks during the Democratic debate in Las Vegas, October 13, 2015. (photo: Lucy Nicholson/Reuters)
Presidential candidate Hillary Clinton speaks during the Democratic debate in Las Vegas, October 13, 2015. (photo: Lucy Nicholson/Reuters)


ALSO SEE: Clinton Urges Federal Actions in Response to
Turing Pharmaceuticals’ Unfair Price Hike of Life-Saving Drug

Clinton Urges US Regulators to Examine Daraprim Price Hike

By Amanda Becker, Reuters

20 October 15

 

emocratic presidential candidate Hillary Clinton on Monday urged U.S. regulators to determine how to bring lower-cost generic drugs to market more swiftly and combat anticompetitive practices in the pharmaceutical industry.

Clinton's requests to the Food and Drug Administration and the Federal Trade Commission were prompted by what she called the "egregious actions of Turing Pharmaceuticals," according to letters reviewed by Reuters.

The company drew fire from Clinton last month after news reports that it had raised the price of Daraprim, a 62-year-old treatment for a dangerous parasitic infection, to $750 a tablet from $13.50 after acquiring it.

Clinton's criticism sent drug industry stock prices tumbling. Turing Chief Executive Officer Martin Shkreli promised to lower Daraprim's cost to an unspecified price, and Turing is in the midst of a rebranding effort after being mocked on "Saturday Night Live."

In her letter to the FDA, which regulates food and drug safety, Clinton said that Turing has still not "meaningfully lowered the price." The company's decision to "artificially increase the price" exploited vulnerable patients dependent on the drug, which is often used by those with compromised immune systems, Clinton said. (reut.rs/1W2o8Sc)

"The FDA should expedite any pending reviews, and encourage applications for review, of other generic alternatives to Daraprim," Clinton wrote.

The FDA told Reuters it will review the letter and respond directly to the sender, but noted that the agency's review of medicines are a matter of public record.

In her letter to the FTC, a consumer protection agency, Clinton acknowledged it has only "limited authority to address price gouging when it is the result of unilateral action in a market with no competition," but urged it to examine both the industry overall and Turing specifically. (reut.rs/1hO1NF4)

"I believe it would be a great service to the Congress and the Administration if the FTC would study and make recommendations on whether and how our laws might be amended to address this problem," Clinton wrote, offering an indication of how she might attempt to overhaul pharmaceutical practices if elected president in November 2016.

Clinton also asked the FTC to investigate whether Turing's decision to increase Daraprim's cost amounts to the type of anticompetitive behavior the agency can regulate.

The FTC did not immediately respond to a request for comment.

Drug prices are also being scrutinized by Democrats in Congress and U.S. prosecutors. Most pharmaceutical companies regularly raise prices, saying it reflects the drugs' value in the market.

The head of Valeant Pharmaceuticals International Inc, which has also come under fire for raising drug prices and is being investigated by the government, said Monday he predicts lower price increases are ahead for the whole industry.

"The pharmaceutical industry is being aggressively sort of attacked for past pricing actions," CEO J. Michael Pearson told investors. "I do think, given that environment, the pricing that pharmaceutical companies will take in the future will be more modest."

The Daraprim price increase was unusual because it was so large. In interviews, Shkreli has defended the steep hike, and Turing last week announced it was making "improvements" to Daraprim's affordability and accessibility to "clarify any misunderstandings about Turing's pricing and distribution," according to a release.

A Turing spokesman on Monday did not respond to requests to comment on Clinton's letters to the FDA and FTC.

Clinton last month unveiled a plan for a $250 monthly cap on out-of-pocket prescription drug costs and other measures to stop what she calls "price gouging" by pharmaceutical companies.

Turing's Daraprim and Shkreli were featured in a television advertisement run by Clinton's campaign about how she plans to take on "skyrocketing out-of-pocket costs."

"Nobody in America should have to choose between buying the medicine they need and paying their rent," Clinton says in the ad.


e-max.it: your social media marketing partner
 

Comments   

A note of caution regarding our comment sections:

For months a stream of media reports have warned of coordinated propaganda efforts targeting political websites based in the U.S., particularly in the run-up to the 2016 presidential election.

We too were alarmed at the patterns we were, and still are, seeing. It is clear that the provocateurs are far more savvy, disciplined, and purposeful than anything we have ever experienced before.

It is also clear that we still have elements of the same activity in our article discussion forums at this time.

We have hosted and encouraged reader expression since the turn of the century. The comments of our readers are the most vibrant, best-used interactive feature at Reader Supported News. Accordingly, we are strongly resistant to interrupting those services.

It is, however, important to note that in all likelihood hardened operatives are attempting to shape the dialog our community seeks to engage in.

Adapt and overcome.

Marc Ash
Founder, Reader Supported News

 
+6 # nice2bgreat 2015-10-20 10:31
.
Bernie Sanders refuses donation from pharmaceutical profiteer Martin Shkreli, thereby publicizing a long-known issue, and here comes Clinton, morphing into action.

Is Miss Clinton showing that she can direct traffic... too?

Look at you -- getting things done. You go girl.

Well done Hillary. 'Tis the season.

Baby on-board.
.
 
 
+2 # Merlin 2015-10-20 13:23
nice2bgreat 2015-10-20 10:31


Hahahaha! Perfectly stated!

"Baby on-board." is the icing on the cake!
 
 
+4 # nice2bgreat 2015-10-20 10:56
.
Sept. 23, 2015

"[Bernie] Sanders rose to the forefront of the political reaction to Turing’s shenanigans, joining Maryland Representative Elijah Cummings in calling on Shkreli and his company to reconsider their current path."

"According to U.K.-based news outlet the Independent, Sanders also set things in motion to look into the situation with Daraprim via Congressional inquiry."

http://www.inquisitr.com/2440934/did-bernie-sanders-persuade-martin-shkreli-to-lower-the-price-for-aids-drug-daraprim/
.
 
 
+5 # Robbee 2015-10-20 11:48
"Clinton last month unveiled a plan for a $250 monthly cap on out-of-pocket prescription drug costs and other measures to stop what she calls "price gouging" by pharmaceutical companies ...

""Nobody in America should have to choose between buying the medicine they need and paying their rent," Clinton says in the ad."

- limiting price gouging to $250 per month is not going to make prescription drugs affordable for most americans - go bernie!
 

THE NEW STREAMLINED RSN LOGIN PROCESS: Register once, then login and you are ready to comment. All you need is a Username and a Password of your choosing and you are free to comment whenever you like! Welcome to the Reader Supported News community.

RSNRSN